article thumbnail

Gabapentinoids – Gabapentin and Pregabalin: Tasce Bongiovanni, Donovan Maust and Nisha Iyer

GeriPal

2006 Transcript Eric: Welcome to the GeriPal Podcast. I also heard that if you look at all individuals in the US, about 4% of individuals are taking one of the gabapentinoids, 10% over 65. Cochrane Database of Systematic Reviews Review. Annals of IM. This is Eric Widera. Alex: This is Alex Smith.

article thumbnail

Hospice in Prison Part 1: An interview with Michele DiTomas and Keith Knauf

GeriPal

Through a series of events, I started working as a consultant to the Department of Corrections in around 2006, and I was assigned to the California Medical Facility. Eric: And can I ask you, when individuals come into the hospice unit, again, you mentioned that their family, their friend, their friends are their family that are here.

Family 132
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How State and Local Agencies on Aging Help Older Adults: Susan DeMarois, Greg Olsen, and Lindsey Yourman

GeriPal

Started as a direct case manager, worked in a variety of different places including the state legislature and I’ve been with the state office now since 2006. I have 24,500 veterans on our caseload, 14,000 individuals with diagnosed mental health issue, 8,500 with an alcohol and substance abuse. Eric: And Susan?

article thumbnail

HIV, Aging, and Palliative Care: Peter Selwyn and Meredith Greene

GeriPal

There was some at the time, which was 2006 so also, it’s been a while since the guidance has been updated and other guidance for other viral infections like hepatitis B and C. Eric 26:39 But I’m also hearing that 1 out of 10 newly diagnosed cases are not those individuals. Eric 18:33 Why did they do that?

article thumbnail

Guiding an Improved Dementia Experience (GUIDE) Model: A Podcast with Malaz Boustani and Diane Ty

GeriPal

So IU, we have been able to convert our paper, Chris Callahan paper that was published in 2006, the first clinical trial that was positive. Within two years we converted to clinical program serving in a safety net healthcare system, 50% African-American, 6% dual eligible. So they were still have one or two more years with them.